Sutro Biopharma to Participate in Three Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Nov. 2, 2021 /PRNewswire/ — Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.